Canaccord Genuity Reiterates a 'Buy' on STAAR Surgical (STAA); Projecting Strong Growth
Tweet
Share
E-mailGet Alerts STAA Hot Sheet
Price: $23.07 --0%
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on STAAR Surgical (NASDAQ: STAA) price target of $14.50.
Analyst, Jason R. Mills, said, "We reiterate our rating and price target following bullish 2012 guidance, which leads us to increase our ICL sales and gross margin estimates in 2012, 2013 and 2014. Q4 results were solid where it counts, as we believe the quarter’s negatives – i.e., lower “other” revenue and higher non-recurring manufacturing expenses – pale in importance to the positives – i.e., ICL sales (+37% Y/Y; +32% in 2011) and GM (record 69.8% in Q4 vs. our 69.1%E; 2012 guidance of 71.0% vs. our 70.4%E). We believe ICL growth and GM expansion are the two most important drivers of revenue/EPS growth over the next three years, during which we model over 15%/90% CAGR, respectively."
For an analyst ratings summary and ratings history on STAAR Surgical click here. For more ratings news on STAAR Surgical click here.
Shares of STAAR Surgical closed at $10.65 yesterday.
Analyst, Jason R. Mills, said, "We reiterate our rating and price target following bullish 2012 guidance, which leads us to increase our ICL sales and gross margin estimates in 2012, 2013 and 2014. Q4 results were solid where it counts, as we believe the quarter’s negatives – i.e., lower “other” revenue and higher non-recurring manufacturing expenses – pale in importance to the positives – i.e., ICL sales (+37% Y/Y; +32% in 2011) and GM (record 69.8% in Q4 vs. our 69.1%E; 2012 guidance of 71.0% vs. our 70.4%E). We believe ICL growth and GM expansion are the two most important drivers of revenue/EPS growth over the next three years, during which we model over 15%/90% CAGR, respectively."
For an analyst ratings summary and ratings history on STAAR Surgical click here. For more ratings news on STAAR Surgical click here.
Shares of STAAR Surgical closed at $10.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Taylor Devices, Inc. (TAYD) to Buy
- BMO Capital Starts Skyworks Solutions (SWKS) at Market Perform
- BMO Capital Starts Eaton Corporation (ETN) at Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
